Effect of Ibrutinib on Hmphocytic Leukemia: a Single-Center Experience.

Hassan, Hamza; Ammad Ud Din, Mohammad; Jamshed, Saad; Bress, Jonathan; Mustafa, S Shahzad

Hassan, Hamza; Ammad Ud Din, Mohammad; Jamshed, Saad; Bress, Jonathan; Mustafa, S Shahzad.

Afiliación

Hassan H; Department of Hematology & Medical Oncology, Boston University Medical Center, Boston, MA, USA.
Ammad Ud Din M; Department of Internal Medicine, Rochester General Hospital, Rochester, NY, USA.
Jamshed S; Division of Hematology and Oncology, Rochester Regional Health, Rochester, NY, USA.
Bress J; Division of Nephrology, Rochester Regional Health, Rochester, NY, USA.
Mustafa SS; Division of Allergy, Immunology, and Rheumatology, Rochester Regional Health, Rochester, NY, USA.

Hematol Oncol Stem Cell Ther ; 15(4): 208-212, 2022 Dec 23.

Article en En | MEDLINE | ID: mdl-34391729

Asunto(s)

Leucemia Linfocítica Crónica de Células B; Proteínas Tirosina Quinasas; Humanos; Agammaglobulinemia Tirosina Quinasa; Adenina; Leucemia Linfocítica Crónica de Células B/tratamiento farmacológico; Inhibidores de Proteínas Quinasas

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Proteínas Tirosina Quinasas / Leucemia Linfocítica Crónica de Células B Tipo de estudio: Clinical_trials Idioma: En Revista: Hematol Oncol Stem Cell Ther Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google